Hippocratic AI Secures $141 Mn in Series B Funding, Valued at $1.64 Bn

The funding was led by Kleiner Perkins, the renowned venture capital firm known for backing Amazon, Genentech, and Google.

Hippocratic AI, a generative AI company specializing in safety-focused large language models (LLMs) for healthcare, has closed a $141 million Series B funding round, raising its valuation to $1.64 billion.

The funding was led by Kleiner Perkins, the renowned venture capital firm known for backing Amazon, Genentech, and Google.

Existing investors, including SV Angel, Premji, General Catalyst, a16z, NVIDIA, Universal Health Services, and WellSpan Health, also participated in the round.

Hippocratic AI develops generative AI solutions for nondiagnostic healthcare tasks, such as medication onboarding, monthly reconciliation, answering hospital and payor policy questions, and offering electronic health record (EHR) assistance.

The company’s emphasis on safety ensures that its AI tools are reliable and efficient for healthcare providers.

Hippocratic's AI Agent App Store

Alongside the funding announcement, Hippocratic AI introduced the Healthcare AI Agent App Store.

This platform enables clinicians to co-develop AI agents tailored to specific patient conditions, enhancing workflow efficiency.

Agents can be created in less than 30 minutes and undergo rigorous safety testing by both their creators and Hippocratic AI staff.

“Since the founding of Hippocratic AI, we have believed that the best way to build safe and effective AI is through close collaboration with those delivering care. Today, with the launch of our AI Agent App Store, we are directly engaging licensed US clinicians to harness the power of AI,” said Munjal Shah, cofounder and CEO of Hippocratic AI.

Expansion Plans

The Series B funding will support the company’s expansion into new markets, including pharmaceuticals and payor services, as well as new geographies such as EMEA (Europe, Middle East, and Africa), Latin America, and Southeast Asia.

Founded in May 2023, Hippocratic AI initially raised $50 million in seed funding through a round co-led by Andreessen Horowitz and General Catalyst.

Subsequent funding efforts brought the total raised during the seed stage to $137 million. The company’s Series A round added $53 million and an additional $17 million, increasing its valuation to $500 million.

Hippocratic AI has consistently emphasized safety and clinician involvement in its solutions.

It has launched a nurse advisory council to complement its physician advisory council, ensuring its LLMs are developed responsibly.

The company also partnered with Adtalem Global Education to create an academic curriculum for training clinicians on AI usage in healthcare.

In late 2024, Hippocratic AI received its first U.S. patent for its innovative Polaris architecture, which underpins its safety-focused LLM.

Stay tuned for more such updates on Digital Health News.